HKEX:1301 stock news
This page provides real-time market news, earnings updates, and company announcements related to D&G Technology Holding Company Limited (HKEX:1301).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-17 07:01 HKT
Monopar Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Business Update
Finviz2026-03-27 17:03:07
CBAK Energy Reports Fourth Quarter and Full Year 2025 Unaudited Financial Results
Finviz2026-03-30 10:03:39
Neumora Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 10:57:50
Unicycive Therapeutics Announces Full Year 2025 Financial Results and Provides Business Update
Finviz2026-03-30 11:09:44
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Finviz2026-03-30 11:51:48
Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology
Finviz2026-03-30 12:03:46
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-30 12:03:47
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results
Finviz2026-03-30 20:06:12
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Finviz2026-03-30 20:06:12
Aptera Motors Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 20:24:42
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 20:54:50
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
Finviz2026-03-31 11:03:09
NervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-31 11:48:43
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Finviz2026-03-31 12:03:48
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-31 20:48:56
PEDEVCO Reports Fourth Quarter and Full-Year 2025 Results
Finviz2026-03-31 21:51:10
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
Finviz2026-04-01 13:03:53
Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-04-02 10:54:51
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Finviz2026-04-07 11:06:54
Jaguar Health Reports 2025 Financials
Finviz2026-04-07 12:33:46
Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026
Finviz2026-04-12 22:03:06
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Finviz2026-04-13 12:03:58
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Finviz2026-04-13 12:03:59
Eikon Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides Clinical and Corporate Updates
Finviz2026-03-30 11:51:48
Lotus For Me SUV Officially Launches: Redefining Performance and Versatility with X-Hybrid Technology
Finviz2026-03-30 12:03:46
Vor Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-30 12:03:47
FLOWERS FOODS ANNOUNCES DEPARTURE OF CHIEF GROWTH OFFICER TERRY THOMAS
Finviz2026-03-30 13:03:04
Aktis Oncology Announces FDA Clearance of Investigational New Drug Applications for AKY-2519 and Provides Business Updates and Full Year 2025 Financial Results
Finviz2026-03-30 20:06:12
Annexon Reports Fourth Quarter and Year-End 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones
Finviz2026-03-30 20:06:12
Aptera Motors Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 20:24:42
Ensysce Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-30 20:54:50
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
Finviz2026-03-31 11:03:09
NervGen Pharma Reports Full Year 2025 Financial Results and Provides Business Updates
Finviz2026-03-31 11:48:43
Allarity Therapeutics Reports Full Year 2025 Financial Results and Corporate Progress
Finviz2026-03-31 12:03:48
Kodiak Sciences Announces Recent Business Highlights and Fourth Quarter and Full Year 2025 Financial Results
Finviz2026-03-31 20:48:56
PEDEVCO Reports Fourth Quarter and Full-Year 2025 Results
Finviz2026-03-31 21:51:10
NeOnc Provides Business Update and Reports Q4 2025 Financial Results
Finviz2026-04-01 13:03:53
Pharvaris Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Finviz2026-04-02 10:54:51
Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center
Finviz2026-04-07 11:06:54
Jaguar Health Reports 2025 Financials
Finviz2026-04-07 12:33:46
Kornit Digital Redefines Apparel Production for the On-Demand Era Unveiling Atlas MATRIX at Konnections 2026
Finviz2026-04-12 22:03:06
Septerna Announces Initiation of Phase 1 Clinical Trial of SEP-479, an Oral Small Molecule PTH1R Agonist for the Treatment of Hypoparathyroidism
Finviz2026-04-13 12:03:58
Geron Announces Appointment of Timothy Williams as Executive Vice President, Chief Legal Officer and Corporate Secretary
Finviz2026-04-13 12:03:59
HKEX:1301 stock price change
On the last trading day, HKEX:1301 stock closed at 0.32 HKD, with a price change of 0.00% for the day.
Trade stock perpsHKEX:1301 stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more